AU4468185A - 2-amino-4-substituted oxazolines - Google Patents
2-amino-4-substituted oxazolinesInfo
- Publication number
- AU4468185A AU4468185A AU44681/85A AU4468185A AU4468185A AU 4468185 A AU4468185 A AU 4468185A AU 44681/85 A AU44681/85 A AU 44681/85A AU 4468185 A AU4468185 A AU 4468185A AU 4468185 A AU4468185 A AU 4468185A
- Authority
- AU
- Australia
- Prior art keywords
- radical
- lower alkyl
- hydrogen
- equal
- denotes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 2-amino-4-substituted oxazolines Chemical class 0.000 title abstract 12
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 5
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000007524 organic acids Chemical class 0.000 abstract 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- YAXGBZDYGZBRBQ-UHFFFAOYSA-N 4,5-dihydro-1,3-oxazol-2-amine Chemical class NC1=NCCO1 YAXGBZDYGZBRBQ-UHFFFAOYSA-N 0.000 abstract 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 abstract 1
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical compound F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000005530 alkylenedioxy group Chemical group 0.000 abstract 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical compound O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The subject matter is specifically the 2-aminooxazolines of general formula <IMAGE> in which Z is hydrogen, a halogen atom, a lower alkyl radical, a lower alkoxy radical, a trifluoromethyl radical, a trifluoromethoxy, cyano, nitro or carboxamido radical, a lower alkenyl radical, a (lower alkyl)thio radical, an alkylenedioxy group, a cycloalkenyl or lower cycloalkyl radical X denotes oxygen, sulphur, an imino radical of formula <2bL>N-R1- in which R1 is hydrogen or a lower alkyl radical or an acyl radical derived from a carboxylic or sulphonic organic acid - a methylene radical or a direct bond. Y denotes hydrogen, a lower alkyl radical, an unsubstituted or substituted phenyl radical, a hydroxyl or a phenoxy radical Y' denotes hydrogen or else Y and Y' together form the oxygen of a carbonyl group or else Y forms with the adjacent phenyl radical, when n is equal to zero, a saturated or unsaturated bicyclic, homocyclic or heterocyclic structure, R3 and R4, which are similar or different, denote hydrogen, a lower alkyl, lower alkenyl, lower aralkyl or (heteroaryl) lower alkyl, aryl, alkoxycarbonyl, aminocarbonyl or acyl radical derived from a carboxylic organic acid containing from 1 to 10 carbon atoms or an amino radical, or else R3 and R4 form with the nitrogen atom to which they are bonded the alkylene chain of a nitrogenous heterocyclic structure optionally interrupted by one or two other heteroatoms R denotes a hydrogen, a lower alkyl radical or an optionally substituted phenyl radical n is equal to zero or 1 n1 is equal to 0, 1 or 2 and p is equal to 1, 2 or 3. The compounds according to the invention may be converted into salts by addition of an inorganic or organic acid, preferably a therapeutically compatible acid. They are used as active principle in antidepressant or antihypertensive pharmaceutical compositions.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH326384 | 1984-07-05 | ||
| CH3263/84 | 1984-07-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU4468185A true AU4468185A (en) | 1986-01-30 |
| AU579872B2 AU579872B2 (en) | 1988-12-15 |
Family
ID=4252197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU44681/85A Expired - Fee Related AU579872B2 (en) | 1984-07-05 | 1985-07-08 | 2-amino-4-substituted oxazolines |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0167459B1 (en) |
| JP (1) | JPS61155375A (en) |
| AT (1) | ATE69222T1 (en) |
| AU (1) | AU579872B2 (en) |
| CA (1) | CA1258040A (en) |
| DD (1) | DD240015A5 (en) |
| DE (1) | DE3584584D1 (en) |
| DK (1) | DK302185A (en) |
| ES (2) | ES8700853A1 (en) |
| HU (1) | HU193333B (en) |
| MA (1) | MA20480A1 (en) |
| OA (1) | OA08166A (en) |
| PL (1) | PL254398A1 (en) |
| PT (1) | PT80779B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2632860A1 (en) * | 1988-06-21 | 1989-12-22 | Rolland Sa A | Novel antidepressant medicaments and pharmaceutical compositions containing them |
| US5948820A (en) | 1994-08-22 | 1999-09-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzene compound and pharmaceutical use thereof |
| KR100358922B1 (en) * | 1994-08-22 | 2003-01-24 | 미쯔비시 웰 파마 가부시키가이샤 | Benzene compound and medicinal use thereof |
| KR100836547B1 (en) | 2002-01-11 | 2008-06-10 | 상꾜 가부시키가이샤 | Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| WO2005079788A1 (en) | 2004-02-24 | 2005-09-01 | Sankyo Company, Limited | Amino alcohol compound |
| RU2473545C2 (en) | 2007-02-02 | 2013-01-27 | Ф.Хоффманн-Ля Рош Аг | New 2-aminooxazolines as taar1 ligands for cns diseases |
| RU2460725C2 (en) | 2007-02-15 | 2012-09-10 | Ф. Хоффманн-Ля Рош Аг | Novel 2-aminooxazolines as taar1 ligands |
| BRPI0907563A2 (en) | 2008-02-18 | 2015-08-04 | Hoffmann La Roche | 4,5-Dihydroxazol-2-ylamine derivatives |
| WO2010010014A1 (en) * | 2008-07-24 | 2010-01-28 | F. Hoffmann-La Roche Ag | 4,5-dihydro-oxazol-2-yl derivatives |
| US8242153B2 (en) | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
| US8354441B2 (en) | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| US8673950B2 (en) | 2010-11-02 | 2014-03-18 | Hoffmann-Laroche Inc. | Dihydrooxazol-2-amine derivatives |
| RU2731095C2 (en) | 2016-03-17 | 2020-08-28 | Ф. Хоффманн-Ля Рош Аг | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having taar agonist activity |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2448M (en) * | 1963-02-27 | 1964-04-06 | Mcneilab Inc | Compound of the class of 2-amino-5-aryl-oxazolines and pharmaceutical compositions containing it. |
| FR2444673A1 (en) * | 1978-12-20 | 1980-07-18 | Science Union & Cie | NOVEL TRIFLUOROETHYLAMINES, PROCESSES FOR OBTAINING SAME AND THEIR USE AS MEDICAMENTS |
| US4647557A (en) * | 1982-12-28 | 1987-03-03 | Gerard Moinet | Novel heterocyclic derivatives bearing an amino radical, processes for their production and the pharmaceutical compositions containing them |
-
1985
- 1985-07-03 DK DK302185A patent/DK302185A/en not_active Application Discontinuation
- 1985-07-04 DE DE8585401360T patent/DE3584584D1/en not_active Expired - Fee Related
- 1985-07-04 DD DD85278275A patent/DD240015A5/en unknown
- 1985-07-04 EP EP85401360A patent/EP0167459B1/en not_active Expired - Lifetime
- 1985-07-04 MA MA20705A patent/MA20480A1/en unknown
- 1985-07-04 AT AT85401360T patent/ATE69222T1/en not_active IP Right Cessation
- 1985-07-05 OA OA58630A patent/OA08166A/en unknown
- 1985-07-05 PT PT80779A patent/PT80779B/en unknown
- 1985-07-05 JP JP60148123A patent/JPS61155375A/en active Pending
- 1985-07-05 CA CA000486391A patent/CA1258040A/en not_active Expired
- 1985-07-05 PL PL25439885A patent/PL254398A1/en unknown
- 1985-07-05 ES ES544926A patent/ES8700853A1/en not_active Expired
- 1985-07-05 HU HU852621A patent/HU193333B/en unknown
- 1985-07-08 AU AU44681/85A patent/AU579872B2/en not_active Expired - Fee Related
-
1986
- 1986-03-15 ES ES553058A patent/ES8705364A1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES8700853A1 (en) | 1986-10-16 |
| HUT38918A (en) | 1986-07-28 |
| JPS61155375A (en) | 1986-07-15 |
| OA08166A (en) | 1987-03-31 |
| EP0167459A3 (en) | 1987-02-25 |
| CA1258040A (en) | 1989-08-01 |
| EP0167459B1 (en) | 1991-11-06 |
| DE3584584D1 (en) | 1991-12-12 |
| AU579872B2 (en) | 1988-12-15 |
| HU193333B (en) | 1987-09-28 |
| PT80779B (en) | 1987-01-12 |
| DK302185D0 (en) | 1985-07-03 |
| PT80779A (en) | 1985-08-01 |
| DK302185A (en) | 1986-01-06 |
| ATE69222T1 (en) | 1991-11-15 |
| ES553058A0 (en) | 1987-05-01 |
| ES8705364A1 (en) | 1987-05-01 |
| ES544926A0 (en) | 1986-10-16 |
| EP0167459A2 (en) | 1986-01-08 |
| DD240015A5 (en) | 1986-10-15 |
| PL254398A1 (en) | 1986-06-17 |
| MA20480A1 (en) | 1986-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU579872B2 (en) | 2-amino-4-substituted oxazolines | |
| AU3628289A (en) | 1-indolylalkyl-4-(substituted pyridinyl) piperazines | |
| ATE128975T1 (en) | UREA DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICATIONS CONTAINING SAME. | |
| EA200100755A1 (en) | 4-OXO-1,4-DIHYDRO-3-QUINOLINKARBOXAMIDES AS ANTI-VIRUS AGENTS | |
| FI885594A (en) | THIAZOLIDINDIONER ANVAENDBARA FOER SAENKANDE AV BLODSOCKERHALTEN SAMT ATHEROSKLEROSIS HINDRANDE MEDEL. | |
| ES8703410A1 (en) | Anti-inflammatory guanidines, their preparation and compositions containing them. | |
| IL110979A (en) | Substituted 17beta-anilide-4-aza-5alpha-androstan-3-ones their preparation and pharmaceutical compositions containing them | |
| ES2010284A6 (en) | Thiourea derivatives | |
| PE20000645A1 (en) | DERIVATIVES OF 3- (2-OXO- [1,3`] BIPYRROLIDINYL-3-ILIDENMETIL) -CEPHEMS | |
| NZ240978A (en) | Benzoxazinone and benzothiazinone derivatives, preparation and pharmaceutical compositions thereof | |
| EP1057485A4 (en) | Potassium channel activators | |
| IL83216A (en) | 1((5-(10->9)abeo-6-methylergolin-8beta-yl)methyl)-imidazolidine-(and hexahydropyrimidine)-2,4-dione derivatives,their preparation and pharmaceutical compositions containing them | |
| DE3070032D1 (en) | Aminoalkyl benzofuran derivatives, their production and compositions containing them | |
| TH5599EX (en) | Derivatives of carbamoilloxythiophene | |
| TH5599A (en) | Derivatives of carbamoilloxythiophene |